Search Results - "Villanucci, A"

Refine Results
  1. 1
  2. 2

    Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma by Raspollini, M. R., Castiglione, F., Rossi Degl'Innocenti, D., Amunni, G., Villanucci, A., Garbini, F., Baroni, G., Taddei, G. L.

    Published in Annals of oncology (01-04-2005)
    “…Background: Significant progress has been made in understanding the molecular biology of ovarian carcinoma. Along with the molecular characteristics of cancer,…”
    Get full text
    Journal Article
  3. 3

    Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma by Raspollini, M R, Amunni, G, Villanucci, A, Baroni, G, Boddi, V, Taddei, G L

    “…The aim of the study was to test the prognostic value of the microvessel density (MVD) within the tumor and the vascular endothelial growth factor (VEGF)…”
    Get more information
    Journal Article
  4. 4

    Uterine sarcoma: twenty-seven years of experience by Livi, L, Paiar, F, Shah, N, Blake, P, Villanucci, A, Amunni, G, Barca, R, Judson, I, Lodge, N, Meldolesi, E, Simontacchi, G, Piperno, G, Galardi, A, Scoccianti, S, Biti, G P, Harmer, C

    “…A correlation of treatment for uterine sarcoma with outcome, prognostic importance of pathology, and clinical parameters. One hundred forty-one patients…”
    Get more information
    Journal Article
  5. 5

    Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome by Raspollini, M.R, Amunni, G, Villanucci, A, Boddi, V, Baroni, G, Taddei, A, Taddei, G.L

    Published in Gynecologic oncology (01-03-2004)
    “…Objectives. Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) play a critical role in cancer development. We investigated iNOS and COX-2…”
    Get full text
    Journal Article
  6. 6

    c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study by Raspollini, M. R., Amunni, G., Villanucci, A., Baroni, G., Taddei, A., Taddei, G. L.

    Published in Annals of oncology (01-04-2004)
    “…Background: Recent studies have shown that several tumours express c-KIT, a growth factor receptor with tyrosine kinase activity; moreover, clinical results…”
    Get full text
    Journal Article
  7. 7

    Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival by Raspollini, M R, Amunni, G, Villanucci, A, Boddi, V, Taddei, G L

    “…The aim of the study is to test the prognostic value of cyclooxygenase-2 (COX-2) and P-glycoprotein in relation to responsiveness to chemotherapy in ovarian…”
    Get more information
    Journal Article
  8. 8

    PP120. Hydatidiform mole as a cause of eclampsia in the first trimester: A case report by Ottanelli, S, Simeone, S, Serena, C, Rambaldi, M.P, Villanucci, A, Tavella, K, Amunni, G, Mecacci, F, Mello, G

    Published in Pregnancy hypertension (01-07-2012)
    “…Introduction The occurrence of preeclampsia before the 20th week of gestation is rare and it has been associated with hydatidiform molar pregnancy. Objectives…”
    Get full text
    Journal Article
  9. 9

    Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients by Susini, T, Amunni, G, Busi, E, Villanucci, A, Carriero, C, Taddei, G, Marchionni, M, Scarselli, G

    “…Gynecological oncologists are faced with an increasing proportion of geriatric ovarian cancer patients. Comorbidities are frequently a matter of concern in…”
    Get more information
    Journal Article
  10. 10

    Microvessel density in ovarian carcinoma: computer image analysis in patients with shorter and longer survival by Raspollini, M R, Amunni, G, Villanucci, A, Baroni, G, Boddi, V, Rossi Degl'innocenti, D, Taddei, G L

    “…We previously reported that tumor microvessel density (MVD) may have prognostic significance in ovarian carcinoma. The aim of this study was to compare the…”
    Get more information
    Journal Article
  11. 11

    Cyclooxygenase-2 Expression in Uterine Leiomyosarcomas by Raspollini, M.R., Amunni, G., Villanucci, A., Paglierani, M., Taddei, G.L.

    Published in Journal of chemotherapy (Florence) (01-12-2004)
    “…Many studies have focused on cyclooxygenase-2 (COX-2) alterations as a critical step in the onset and progression of cancer. Moreover, a strong correlation…”
    Get full text
    Journal Article
  12. 12

    The Use of Intravenous Methotrexate in the Treatment of Ectopic Pregnancy by Periti, E., Comparetto, C., Villanucci, A., Coccia, M.E., Tavella, K., Amunni, G.

    Published in Journal of chemotherapy (Florence) (01-04-2004)
    “…Between January 1996 and December 2001, at the Department of Gynecology, Perinatology and Human Reproduction of the University of Florence, 49 ectopic…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Estrogen and Progesterone Receptors Expression in Uterine Malignant Smooth Muscle Tumors: Correlation with Clinical Outcome by Raspollini, M.R., Amunni, G., Villanucci, A., Boddi, V., Simoni, A., Taddei, A., Taddei, G.L.

    Published in Journal of chemotherapy (Florence) (01-12-2003)
    “…Uterine leiomyosarcomas are associated with a poor prognosis, although a considerable diversity in behavior may be found, and prolonged survival may occur. The…”
    Get full text
    Journal Article
  15. 15

    C-kit Expression in Uterine Leiomyosarcomas: An Immunocytochemical Study of 29 Cases of Malignant Smooth Muscle Tumors of the Uterus by Raspollini, M.R., Villanucci, A., Amunni, G., Paglierani, M., Taddei, A., Taddei, G.L.

    Published in Journal of chemotherapy (Florence) (01-02-2003)
    “…Uterine malignant stromal tumors are rare neoplasms characterized by fatal prognosis. At the moment no effective systemic treatment is available for…”
    Get full text
    Journal Article
  16. 16

    Prognostic Value of P-glycoprotein and Proliferative Index in Advanced Low Grade Serous Ovarian Carcinomas by Raspollini, M.R., Amunni, G., Villanucci, A., Baroni, G., Boddi, V., Taddei, G.L.

    Published in Journal of chemotherapy (Florence) (01-08-2003)
    “…The aim of this study was to test the prognostic value of p-glycoprotein expression and the proliferative index of tumor cells on the clinical response to…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Multidrug Resistance in Ovarian Cancer: Comparing an Immunocytochemical Study and ATP-Tumor Chemosensitivity Assay by Raspollini, M.R., Pinzani, P., Pazzagli, M., Baroni, G., Taddei, A., Amunni, G., Villanucci, A., Taddei, G.L.

    Published in Journal of chemotherapy (Florence) (01-10-2002)
    “…The aim of our study was to evaluate the possible prognostic and predictive significance of the expression of P-glycoprotein, a transmembrane transport protein…”
    Get full text
    Journal Article
  19. 19

    Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study by De Angelis, Verena, Roila, Fausto, Tonato, Maurizio, Ballatori, Enzo, Del Favero, Albano

    Published in Tumori (01-11-2001)
    “…The necessity of an antiemetic prophylaxis in patients treated with chemotherapy of low emetogenic potential, such as 5-fluorouracil +/- folinic acid…”
    Get full text
    Journal Article
  20. 20

    c-Kit expression in patients with uterine leiomyosarcomas: A potential alternative therapeutic treatment by RASPOLLINI, Maria Rosaria, AMUNNI, Gianni, VILLANUCCI, Alessandro, PINZANI, Pamela, SIMI, Lisa, PAGLIERANI, Milena, TADDEI, Gian Luigi

    Published in Clinical cancer research (15-05-2004)
    “…Uterine leiomyosarcomas are rare tumors characterized by their resistance to chemotherapy and radiation treatment. Surgery is the primary method of treatment,…”
    Get full text
    Journal Article